| Blog results | Results 1 - 10 of about 4,817 for mds leukemia. (0.29 seconds) |
| Sorted by relevance Sort by date |
| 8 Nov 2009 Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients. The purpose of this study is to determine whether addition of AS101 to the standard chemotherapy regimen is ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 2 Nov 2009 by Tukky When the explosion of cell occurrence is found in low proportions doctors see the disease as MDS. If there are higher proportions, the state has deteriorated into a colon cancer and is known as the MDS-leukemia. Thus, MDS and leukemia ... The Progessive - http://theprogessive.blogspot.com/ |
| 2 Nov 2009 by admin If there are higher proportions, the state has deteriorated into a colon cancer and is known as the MDS- leukemia . Thus, MDS and leukemia are often linked together and have the same methods of treatment. See the original post here: ... Leukemia - http://leukemia.hostei.com/ [ More results from Leukemia ] |
| 18 Nov 2009 by Kitamura T Related Articles. [Molecular bases of leukemia, MPD and MDS]. Rinsho Ketsueki. 2009 Mar;50(3):174-81. Authors: Kitamura T. PMID: 19352084 [PubMed - indexed for MEDLINE] Blood Research Papers, Journals, Pubmed - http://pubmeddy.com/blood/ |
| 6 Nov 2009 by Ani They believe that the new gene called RhoB could prove to be a therapeutic target for late-stage MDS. Developer of Stratosphere Tower in Las Vegas dies after battle with leukemia. September 25th, 2009 Las Vegas' Stratosphere developer ... Health News - http://blog.taragana.com/health/ - References [ More results from Health News ] |
| 17 Nov 2009 (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of advanced myeloid leukemia (AML) and myelodysplastic syndromes (MDS) will be ... GlobeNewswire: Pharmaceuticals News - http://www.globenewswire.com/newsroom/?kw=PHARMACEUTICALS |
| 18 Aug 2009 He has gone from MDS to Acute Leukemia. He & his family need your support, financially & emotionally. He is now being treated with chemo in the US & will be admitted into Crittenton Hospital, in Rochester, MI. today, here he will be ... Windsor Star - News / Windsor - http://www2.canada.com/840944.atom?id=840944&viewer=http://www.wi... [ More results from Windsor Star - News / Windsor ] |
| 27 Oct 2009 by Tiny with myelodysplastic syndrome mds. Leukemia & Lymphoma Society - Myelodysplastic Syndromes Facts & Statistics The term "myelodysplastic syndromes" or MDS describes a group of blood cancers. . under 50 with a severe form of ... Health Resources - http://www.health-res.com/ |
| 5 Nov 2009 Donations in her memory may be made to the Dana Farber Cancer Institute for MDS/Leukemia, 10 Brookline Place West, 6th Floor, Brookline, MA 02445. Smith & Heald Funeral Home, Milford, is handling arrangements. ... CabinetPress.com | Web Feeds - http://www.cabinet.com/ |
| 10 Nov 2009 The company is developing omacetaxine, its lead product candidate, for the treatment of patients with Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS). A New Drug Application has been ... Drugs.com - New Drug Applications - http://www.drugs.com/new-drug-applications.html - References [ More results from Drugs.com - New Drug Applications ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |